Ena Respiratory researches and develops solutions to transform the treatment and prevention of respiratory infections.
Ena Respiratory has raised $2.1M in total funding. The most recent round was Grant. The last funding was announced in September 2026.
Ena Respiratory's investors include Bill & Melinda Gates Foundation, U.S. Department of War, Brandon Capital, Uniseed, Stoic VC.
Ena Respiratory is headquartered in Melbourne, Australia.
Ena Respiratory researches and develops solutions to transform the treatment and prevention of respiratory infections.
Ena Respiratory is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ena Respiratory — Funding & Investors." VCBacked, September 4, 2026, https://www.vcbacked.co/company/ena-respiratory. Accessed October 21, 2026.
VCBacked. (2026). Ena Respiratory — Funding & Investors. Retrieved October 21, 2026, from https://www.vcbacked.co/company/ena-respiratory
{{cite web |title=Ena Respiratory — Funding & Investors |url=https://www.vcbacked.co/company/ena-respiratory |website=VCBacked |access-date=October 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated